Protalix BioTherapeutics (PLX) Interest & Investment Income (2024 - 2026)
Protalix BioTherapeutics (PLX) posted quarterly Interest & Investment Income of $188000.0 for Q1 2026, down 55.13% year-over-year from $419000.0 in Q1 2025, and down 29.32% quarter-over-quarter from $266000.0 in Q4 2025.
Protalix BioTherapeutics (PLX) Interest & Investment Income (2024 - 2026) Analysis & Trends
Protalix BioTherapeutics' Interest & Investment Income history runs 3 years deep, the most recent figure standing at $188000.0 for Q1 2026.
- In Q1 2026, Interest & Investment Income fell 55.13% year-over-year to $188000.0; the TTM figure through Mar 2026 stood at $1.0 million (down 23.91% YoY), while the FY2025 annual figure was $1.1 million, down 16.63% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $188000.0, down from $266000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $419000.0 in Q1 2025, with the low at $188000.0 in Q1 2026.
- The 3-year median for Interest & Investment Income is $280500.0 (2025), against an average of $293625.0.
- The sharpest annual moves came in 2025 and 2026: Interest & Investment Income jumped 36.32% in 2025, then slumped 55.13% in 2026.
- Protalix BioTherapeutics' Interest & Investment Income stood at $329000.0 in 2024, then dropped by 19.15% to $266000.0 in 2025, then retreated by 29.32% to $188000.0 in 2026.
- Business Quant data shows PLX's Interest & Investment Income at $188000.0 in Q1 2026, $266000.0 in Q4 2025, and $289000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | Protalix BioTherapeutics | 189.97 Mn | 149.31 Mn | 12.13 Mn | 660,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 660,000.00 |
| Mar 31, 2026 | 188,000.00 |
| Dec 31, 2025 | 266,000.00 |
| Sep 30, 2025 | 289,000.00 |
| Jun 30, 2025 | 272,000.00 |
| Mar 31, 2025 | 419,000.00 |
| Dec 31, 2024 | 329,000.00 |
| Sep 30, 2024 | 212,000.00 |
| Jun 30, 2024 | 374,000.00 |